Contract development and manufacturing organization (CDMO), Halo Pharma will be discussing its capabilities in topical drug products at CPhI NA, Booth 1549, at the Pennsylvania Convention Center, April 24-26. Topical drug products, which Research and Markets predicts will reach global sales of $194.2 billion by 2024, target localized skin sites or offer systemic penetration by formulations that are easily applied and conveniently packaged. They are complex to formulate as they typically mix o...